Legal Barriers
Cross-source consensus on Legal Barriers from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Evidence quality
Other
Highlighted claims
- Federal Schedule I classification is described as a major obstacle to cannabis research, physician education, funding, clinical progress, and access. — Weed the People, Medical Cannabis, and Pediatric Cancer
- The article contrasts Schedule I status with a 2003 U.S. government patent on CBD as an antioxidant and neuroprotectant. — Weed the People, Medical Cannabis, and Pediatric Cancer
- U.S. cannabis research is described as constrained by scheduling barriers, leaving evidence anecdotal or dependent on other countries. — Weed the People, Medical Cannabis, and Pediatric Cancer
- Cannabis law is described as uneven and chaotic across state and federal systems. — Weed the People, Medical Cannabis, and Pediatric Cancer